Literature DB >> 16386516

Chronic kidney disease in renal transplant recipients.

R Marcén1, J Pascual, M Tenorio, E J Ocaña, J L Teruel, J J Villafruela, M Fernández, F J Burgos, J Ortuño.   

Abstract

UNLABELLED: The aim of the present study was to investigate the utility in renal transplant patients of the guidelines for the diagnosis and classification of chronic kidney disease (CKD) based on the estimated glomerular filtration rate (GFR) elaborated by the Kidney Disease Outcomes Quality Initiative (K/DOQI) of the National Kidney Foundation. PATIENTS AND METHODS: Four hundred forty-seven cadaveric kidney transplants performed between 1980 and 1994 with graft function at 12 months were included in the study. The GFR was calculated according to the MDRD equation.
RESULTS: The mean GFR at 12 months was 54.5 +/- 20.3 mL/min/1.73 m(2): 23 patients (5.1%) had a GFR > or =90 mL/min/1.73 m(2); 136 patients (30.6%), 60-89; 246 (54.7%), 30-59; 35 patients (7.8%), 15-29; and 7 patients (1.6%), GFR <15. Similar distribution of CKD stages was observed at 5 and 10 years. Unadjusted graft survival at 10 years was better among patients with a higher GFR at 12 months: 87% in patients with GFR >90 mL/min/1.73 m(2); 83% of GFR 60-89 mL/min/1.73 m(2); 63%, GFR 30-59 mL/min/1.73 m(2); and 23%, GFR <30 mL/min/1.73 m(2) (P < .001). The association between GFR and graft survival persisted when adjusted by the age and gender of the recipients and donors, time on dialysis, body mass index, immunosuppression, delayed graft function, rejection, and HLA mismatches. The prevalence of complications, such as anemia, hypertension, dyslipidemias, and number of drugs increased as GFR declined.
CONCLUSIONS: More than 60% of recipients presented chronic kidney disease. GFR was a predictive factor for graft survival at 10 years. The classification of renal transplant patients by CKD stages may help to identify patients with increased risk of graft loss and also to design strategies to improve outcomes.

Entities:  

Mesh:

Year:  2005        PMID: 16386516     DOI: 10.1016/j.transproceed.2005.09.101

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Five-year safety and efficacy of belatacept in renal transplantation.

Authors:  Flavio Vincenti; Gilles Blancho; Antoine Durrbach; Peter Friend; Josep Grinyo; Philip F Halloran; Jurgen Klempnauer; Philippe Lang; Christian P Larsen; Ferdinand Mühlbacher; Björn Nashan; Jean-Paul Soulillou; Yves Vanrenterghem; Thomas Wekerle; Mamta Agarwal; Sheila Gujrathi; Jinshan Shen; Rebecca Shi; Robert Townsend; Bernard Charpentier
Journal:  J Am Soc Nephrol       Date:  2010-07-15       Impact factor: 10.121

2.  Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation.

Authors:  Clément Mottola; Nicolas Girerd; Kevin Duarte; Alice Aarnink; Magali Giral; Jacques Dantal; Valérie Garrigue; Georges Mourad; Fanny Buron; Emmanuel Morelon; Marc Ladrière; Michèle Kessler; Luc Frimat; Sophie Girerd
Journal:  Clin Kidney J       Date:  2020-04-26

3.  Long-term graft function changes in kidney transplant recipients.

Authors:  Roberto Marcén; José María Morales; Ana Fernández-Rodriguez; Luis Capdevila; Luis Pallardó; Juan José Plaza; Juan José Cubero; Josep María Puig; Ana Sanchez-Fructuoso; Manual Arias; Gabriela Alperovich; Daniel Serón
Journal:  NDT Plus       Date:  2010-06

4.  Characteristics and Outcomes of Kidney Transplant Recipients with a Functioning Graft for More than 25 Years.

Authors:  Sandesh Parajuli; Didier A Mandelbrot; Fahad Aziz; Neetika Garg; Brenda Muth; Maha Mohamed; Michael J Armbrust; Brad C Astor; Arjang Djamali
Journal:  Kidney Dis (Basel)       Date:  2018-07-27

5.  Conversion to mTOR-inhibitor-based immunosuppression: which patients and when?

Authors:  Philippe Gatault; Yvon Lebranchu
Journal:  Transplant Res       Date:  2013-11-20

6.  Derivation of a Predictive Model for Graft Loss Following Acute Kidney Injury in Kidney Transplant Recipients.

Authors:  Amber O Molnar; Carl van Walraven; Dean Fergusson; Amit X Garg; Greg Knoll
Journal:  Can J Kidney Health Dis       Date:  2017-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.